Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$126.43 - $145.6 $1,264 - $1,456
-10 Reduced 0.23%
4,387 $638,000
Q1 2023

May 15, 2023

BUY
$121.91 - $130.94 $2,438 - $2,618
20 Added 0.46%
4,397 $568,000
Q4 2022

Feb 14, 2023

BUY
$104.7 - $128.4 $458,271 - $562,006
4,377 New
4,377 $558,000
Q3 2022

Nov 14, 2022

BUY
$101.65 - $119.27 $474,502 - $556,752
4,668 New
4,668 $486,000
Q2 2022

Aug 15, 2022

BUY
$102.23 - $133.85 $2,555 - $3,346
25 Added 0.52%
4,806 $504,000
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $6,579 - $8,357
57 Added 1.21%
4,781 $589,000
Q3 2021

Nov 03, 2021

BUY
$136.35 - $158.76 $3,136 - $3,651
23 Added 0.49%
4,724 $671,000
Q1 2021

May 13, 2021

BUY
$148.16 - $159.71 $27,705 - $29,865
187 Added 4.14%
4,701 $730,000
Q4 2020

Feb 12, 2021

SELL
$128.25 - $151.41 $53,223 - $62,835
-415 Reduced 8.42%
4,514 $675,000
Q3 2020

Nov 13, 2020

BUY
$113.59 - $141.68 $2,839 - $3,542
25 Added 0.51%
4,929 $651,000
Q2 2020

Aug 14, 2020

SELL
$87.02 - $133.4 $3,480 - $5,336
-40 Reduced 0.81%
4,904 $568,000
Q1 2019

May 15, 2019

SELL
$97.5 - $125.79 $44,655 - $57,611
-458 Reduced 8.48%
4,944 $0
Q4 2018

Feb 15, 2019

BUY
$94.4 - $126.76 $80,145 - $107,619
849 Added 18.65%
5,402 $543,000
Q3 2018

Nov 14, 2018

SELL
$108.41 - $127.64 $43,255 - $50,928
-399 Reduced 8.06%
4,553 $0
Q2 2018

Aug 08, 2018

BUY
$102.12 - $114.04 $40,745 - $45,501
399 Added 8.76%
4,952 $0
Q1 2018

May 16, 2018

SELL
$104.31 - $124.46 $239,495 - $285,760
-2,296 Reduced 33.52%
4,553 $0
Q4 2017

Feb 15, 2018

SELL
$105.55 - $120.83 $65,546 - $75,035
-621 Reduced 8.31%
6,849 $0
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $798,692 - $879,891
7,470
7,470 $0

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.